Total Assets Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual total assets in 2023 was 2.29 Billion TWD , down -8.66% from previous year.
Apex Biotechnology Corp.'s latest quarterly total assets in 2024 Q2 was 2.29 Billion TWD , down -1.69% from previous quarter.
Apex Biotechnology Corp. reported annual total assets of 2.51 Billion TWD in 2022, down -5.83% from previous year.
Apex Biotechnology Corp. reported annual total assets of 2.67 Billion TWD in 2021, up 0.72% from previous year.
Apex Biotechnology Corp. reported quarterly total assets of 2.29 Billion TWD for 2024 Q2, down -1.69% from previous quarter.
Apex Biotechnology Corp. reported quarterly total assets of 2.25 Billion TWD for 2023 Q3, down -5.63% from previous quarter.

Annual Total Assets Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Total Assets of Apex Biotechnology Corp. (2023 - 2009)

Year	Total Assets	Total Assets Growth
2023	2.29 Billion TWD	-8.66%
2022	2.51 Billion TWD	-5.83%
2021	2.67 Billion TWD	0.72%
2020	2.65 Billion TWD	-5.78%
2019	2.81 Billion TWD	10.55%
2018	2.54 Billion TWD	-5.71%
2017	2.69 Billion TWD	7.96%
2016	2.5 Billion TWD	-7.19%
2015	2.69 Billion TWD	1.88%
2014	2.64 Billion TWD	-2.9%
2013	2.72 Billion TWD	-0.87%
2012	2.74 Billion TWD	28.47%
2011	2.13 Billion TWD	9.67%
2010	1.95 Billion TWD	9.91%
2009	1.77 Billion TWD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	2.33 Billion TWD	1.61%
2024 Q2	2.29 Billion TWD	-1.69%
2023 Q3	2.25 Billion TWD	-5.63%
2023 Q1	2.42 Billion TWD	-3.74%
2023 Q4	2.29 Billion TWD	1.73%
2023 Q2	2.39 Billion TWD	-1.15%
2023 FY	2.29 Billion TWD	-8.66%
2022 Q2	2.6 Billion TWD	2.51%
2022 FY	2.51 Billion TWD	-5.83%
2022 Q4	2.51 Billion TWD	-2.18%
2022 Q3	2.57 Billion TWD	-1.23%
2022 Q1	2.53 Billion TWD	-4.93%
2021 FY	2.67 Billion TWD	0.72%
2021 Q2	2.63 Billion TWD	-3.4%
2021 Q3	2.44 Billion TWD	-6.93%
2021 Q4	2.67 Billion TWD	9.03%
2021 Q1	2.72 Billion TWD	2.75%
2020 Q2	2.77 Billion TWD	-1.14%
2020 Q4	2.65 Billion TWD	0.62%
2020 FY	2.65 Billion TWD	-5.78%
2020 Q1	2.8 Billion TWD	-0.4%
2020 Q3	2.63 Billion TWD	-4.9%
2019 Q3	2.64 Billion TWD	-5.43%
2019 FY	2.81 Billion TWD	10.55%
2019 Q1	2.69 Billion TWD	5.75%
2019 Q2	2.8 Billion TWD	4.07%
2019 Q4	2.81 Billion TWD	6.22%
2018 Q4	2.54 Billion TWD	-3.57%
2018 FY	2.54 Billion TWD	-5.71%
2018 Q3	2.63 Billion TWD	-12.12%
2018 Q2	3 Billion TWD	10.61%
2018 Q1	2.71 Billion TWD	0.6%
2017 Q2	2.77 Billion TWD	9.83%
2017 FY	2.69 Billion TWD	7.96%
2017 Q4	2.69 Billion TWD	-0.07%
2017 Q1	2.52 Billion TWD	1.08%
2017 Q3	2.7 Billion TWD	-2.68%
2016 Q2	2.85 Billion TWD	2.33%
2016 Q1	2.78 Billion TWD	3.43%
2016 FY	2.5 Billion TWD	-7.19%
2016 Q4	2.5 Billion TWD	-12.53%
2016 Q3	2.85 Billion TWD	0.25%
2015 Q3	2.53 Billion TWD	-6.93%
2015 Q2	2.71 Billion TWD	0.44%
2015 FY	2.69 Billion TWD	1.88%
2015 Q1	2.7 Billion TWD	2.37%
2015 Q4	2.69 Billion TWD	6.46%
2014 FY	2.64 Billion TWD	-2.9%
2014 Q4	2.64 Billion TWD	-1.42%
2014 Q3	2.68 Billion TWD	-9.69%
2014 Q2	2.97 Billion TWD	7.97%
2014 Q1	2.75 Billion TWD	1.02%
2013 Q2	2.67 Billion TWD	-7.51%
2013 Q1	2.88 Billion TWD	5.16%
2013 FY	2.72 Billion TWD	-0.87%
2013 Q4	2.72 Billion TWD	1.29%
2013 Q3	2.68 Billion TWD	0.62%
2012 Q2	2.01 Billion TWD	-12.37%
2012 FY	2.74 Billion TWD	28.47%
2012 Q4	2.74 Billion TWD	4.89%
2012 Q3	2.61 Billion TWD	30.01%
2012 Q1	2.29 Billion TWD	7.5%
2011 Q2	2.22 Billion TWD	8.95%
2011 Q3	2.02 Billion TWD	-9.21%
2011 FY	2.13 Billion TWD	9.67%
2011 Q4	2.13 Billion TWD	5.73%
2011 Q1	2.04 Billion TWD	4.87%
2010 Q4	1.95 Billion TWD	0.0%
2010 FY	1.95 Billion TWD	9.91%
2009 FY	1.77 Billion TWD	0.0%

Peer Total Assets Comparison of Apex Biotechnology Corp.

Name	Total Assets	Total Assets Difference
Sinphar Pharmaceutical Co.,Ltd.	6.25 Billion TWD	63.254%
Panion & Bf Biotech Inc.	3.23 Billion TWD	28.999%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	5.17 Billion TWD	55.585%
GenMont Biotech Incorporation	1.65 Billion TWD	-38.944%
Abnova (Taiwan) Corporation	1.35 Billion TWD	-69.428%
Adimmune Corporation	9.48 Billion TWD	75.781%
Tanvex BioPharma, Inc.	2.76 Billion TWD	16.878%
Polaris Group	9.09 Billion TWD	74.753%
Energenesis Biomedical CO.,LTD.	828.57 Million TWD	-177.225%
UnicoCell Biomed Co., Ltd.	685.92 Million TWD	-234.875%
PELL Bio-Med Technology Co. Ltd.	1.41 Billion TWD	-61.971%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Total Assets Summary of Apex Biotechnology Corp.

Annual Total Assets Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Total Assets of Apex Biotechnology Corp. (2023 - 2009)

Peer Total Assets Comparison of Apex Biotechnology Corp.